Lee Hyun Goo, Kim Won Ki, Yeon Je Young, Kim Jong Soo, Kim Keon Ha, Jeon Pyoung, Hong Seung Chyul
Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Department of Neurosurgery, Dongkang Medical Center, Ulsan, Korea.
Yonsei Med J. 2018 Jan;59(1):107-112. doi: 10.3349/ymj.2018.59.1.107.
Contrast-induced acute kidney injury (CI-AKI) is associated with poor outcomes after percutaneous coronary intervention. However, CI-AKI has rarely been evaluated within the neurovascular field. The aim of this study was to investigate the incidence and clinical implication of CI-AKI after coil embolization in patients with an aneurysmal subarachnoid hemorrhage (aSAH).
Between January 2005 and March 2016, 192 patients who underwent coil embolization were enrolled in this study. CI-AKI was defined as an increase from baseline serum creatinine concentration of >25% or >0.5 mg/dL within 72 hours after coil embolization. A poor clinical outcome was defined as a score of ≥3 on the modified Rankin Scale at one-year post-treatment.
A total of 16 patients (8.3%) died as a result of medical problems within one year. CI-AKI was identified in 14 patients (7.3%). Prominent risk factors for one-year mortality included CI-AKI [odds ratio (OR): 16.856; 95% confidence interval (CI): 3.437-82.664] and an initial Glasgow Coma Scale (GCS) score ≤8 (OR: 5.565; 95% CI: 1.703-18.184). A poor clinical outcome was associated with old age (≥65 years) (OR: 7.921; 95% CI: 2.977-21.076), CI-AKI (OR: 11.281; 95% CI: 2.138-59.525), an initial GCS score ≤8 (OR 31.02; 95% CI, 10.669-90.187), and a ruptured aneurysm (p=0.016, OR: 4.278) in posterior circulation.
CI-AKI seems to be an independent predictor of the overall outcomes of aSAH after endovascular treatment.
对比剂诱导的急性肾损伤(CI-AKI)与经皮冠状动脉介入治疗后的不良预后相关。然而,CI-AKI在神经血管领域很少得到评估。本研究的目的是调查动脉瘤性蛛网膜下腔出血(aSAH)患者行弹簧圈栓塞术后CI-AKI的发生率及临床意义。
2005年1月至2016年3月,192例行弹簧圈栓塞术的患者纳入本研究。CI-AKI定义为弹簧圈栓塞术后72小时内血清肌酐浓度较基线升高>25%或>0.5mg/dL。不良临床结局定义为治疗后1年改良Rankin量表评分≥3分。
共有16例患者(8.3%)在1年内因医疗问题死亡。14例患者(7.3%)被诊断为CI-AKI。1年死亡率的显著危险因素包括CI-AKI(比值比[OR]:16.856;95%置信区间[CI]:3.437-82.664)和初始格拉斯哥昏迷量表(GCS)评分≤8分(OR:5.565;95%CI:1.703-18.184)。不良临床结局与老年(≥65岁)(OR:7.921;95%CI:2.977-21.076)、CI-AKI(OR:y11.281;95%CI:2.138-59.525)、初始GCS评分≤8分(OR:31.02;95%CI:10.669-90.187)以及后循环动脉瘤破裂(p=0.016,OR:4.278)有关。
CI-AKI似乎是aSAH血管内治疗后总体结局的独立预测因素。